Fatigue in patients with inflammatory bowel disease in Eastern China

Table 1 Demographic and clinical characteristics of inflammatory bowel disease patients

	CD (n = 168)	UC (n = 143)
Age, yr, median (IQR)	39 (IQR: 28-52.75)	45 (IQR: 33-54)
Gender, n (%)
Female	71 (42.26)	64 (44.76)
Male	97 (57.74)	79 (55.24)
BMI, n (%)
Normal	94 (55.95)	81 (56.64)
Thinnish	60 (35.71)	37 (25.88)
Overweight	11 (6.55)	25 (17.48)
Obesity	3 (1.79)	0 (0)
Marital status, n (%)
Unmarried	58 (34.52)	14 (9.79)
Married	105 (62.50)	126 (88.11)
Divorced	3 (1.79)	3 (2.10)
Death of a spouse	2 (1.19)	0 (0)
Employment status, n (%)
No work	16 (9.52)	13 (9.09)
Full time	117 (69.64)	91 (63.64)
Retired	15 (8.93)	35 (24.48)
Long-term sick leave	1 (0.60)	3 (2.10)
Students	19 (11.31)	1 (0.69)
Medical insurance, n (%)
Yes	151 (89.88)	130 (90.91)
No	17 (10.12)	13 (9.09)
Education, n (%)
Primary school or below	14 (8.33)	20 (13.99)
Junior high school	34 (20.24)	36 (25.17)
Senior high school	32 (19.05)	41 (28.67)
Junior college or Undergraduate	81 (48.21)	42 (29.37)
Master degree or above	7 (4.17)	4 (2.80)
Montreal classification, n (%)
L1 ileal	38 (22.62)
L2 colonic	14 (8.33)
L3 ileocolonic	72 (42.86)
L4 upper gastrointestinal tract	11 (6.55)
L1 + L4	13 (7.74)
L3 + L4	20 (11.90)
E1 proctitis		37 (25.88)
E2 left-sided UC		40 (27.97)
E3 extensive UC		66 (46.15)
Disease activity: n (%)
Remission	100 (59.52)	51 (35.66)
Mild activity	26 (15.48)	43 (30.07)
Moderate activity	31 (18.45)	37 (25.88)
Severe activity	11 (6.55)	12 (8.39)
Duration of disease, yr, median (IQR)	5.50 (IQR, 2-11)	5 (IQR, 2.3-13)
Current medication, n (%)
5-ASA	19 (11.31)	88 (61.54)
IS	42 (25)	30 (20.98)
5-ASA + IS	22 (13.09)	8 (5.59)
Biological preparation	45 (26.79)	5 (3.50)
Biological preparation + IS	34 (20.24)	8 (5.59)
Other	6 (3.57)	4 (2.80)
IBD related surgery, n (%)
No	80 (47.62)	129 (90.21)
Yes	88 (52.38)	14 (9.79)

CD: Crohn's disease; UC: Ulcerative colitis; IBD: Inflammatory bowel disease; 5-ASA: 5-aminosalisylic acid; IQR: Interquartile range; IS: Immunosuppressant.